Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients

计划入组 55 人 · 首次发布于 2021 年 10 月 28 日

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

计划入组 83 人 · 首次发布于 2005 年 8 月 11 日

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

计划入组 20 人 · 首次发布于 2017 年 4 月 11 日

anti-myostatin antibody (obesity)

Myostatin(PeptiDream)

Myostatin (iBio)

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

Compass Therapeutics

United States

Scholar Rock's Myostatin-Blocking Antibody Advances to FDA Review for Spinal Muscular Atrophy

iBio Advances AI-Driven Obesity Pipeline with Myostatin and Activin E Antibody Therapies

Shattuck Labs Announces Key Milestones for SL-325 Program Targeting Inflammatory Diseases